When a hepatic cyst hemorrhage occurs in a patient currently receiving antithrombotic therapy — including anticoagulants, antiplatelet agents, or both — management requires careful consideration of competing risks.
Hepatic cyst with hemorrhage in a patient on current antithrombotic therapy (anticoagulant and/or antiplatelet).
The approach centers on managing antithrombotic agents, with the duration and specifics determined through an individualized assessment of each patient's bleeding and thrombotic risk. The complete protocol — including decision criteria and clinical considerations — is detailed in the full regimen.
Specific guidance and the full decision framework are available in the structured protocol below.
DOI: 10.14701/ahbps.25-070